rabeprazole (Aciphex)
Jump to navigation
Jump to search
Introduction
Tradename: Aciphex. Generic approved nov 2013.[2]
Indications
- duodenal ulcer
- gastroesophageal reflux disease (GERD)
- prevention of GI bleed due to hypersecretory conditions
- reflux esophagitis (treatment & maintenance)
- component of combination therapy for Helicobacter pylori
Dosage
Tabs: 20 mg (delayed release).
Mechanism of action
- proton pump inhibitor
- interacts with sulfhydryl groups in proton pump
- inactive at neutral pH
More general terms
References
- ↑ Kaiser Permanente Northern California Drug Information, 2000
- ↑ Jump up to: 2.0 2.1 FDA News Release: Nov. 8, 2013 FDA approves first generic versions of Aciphex delayed-release tablets to treat GERD. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm374329.htm
- ↑ Jump up to: 3.0 3.1 Deprecated Reference